Search results
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 7 days ago“Brazil has its particularities, like any other country, but we have a dynamic healthcare system, which is a global reference in several areas and of...
Cinven to explore $3 billion sale of software maker Jaggaer, sources say
WSAU Wausau· 7 days agoBy Milana Vinn NEW YORK (Reuters) - Private equity firm Cinven is preparing to explore a sale of Jaggaer that it hopes will value the maker of supply chain software at about $3 billion, including ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoActive Pharmaceutical Ingredient Market Worth $238.3 billion | MarketsandMarkets™ PR Newswire CHICAGO, May 17, 2024 CHICAGO, May 17, 2024 /PRNewswire/ -- Active Pharmaceutical ...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 4 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks· 3 days agoBayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 4 days agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 7 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 5 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 7 days agoEssential Tech for Biotechs Veeva sells cloud-based offerings geared toward the pharmaceutical and...
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe antibody was in-licensed from Merck. With financial backing from Blackstone Life Sciences,...
